4.8 (129) In stock
After 40 years of treating metastatic bladder cancer with chemotherapy as a primary treatment, scientists now present a new approach using immunotherapy combinations. The results of two studies have been presented at the European Society for Medical Oncology (ESMO) conference in Madrid. The outcomes of these studies could revolutionize the landscape of bladder cancer treatment.
Immunotherapy: Pushing the Frontier of Cancer Medicine
Frontiers Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?
Finding new immunotherapy targets - Immune system agonists
Study Finds People with Inflammatory Arthritis Face Significant Psychological Challenges in Maintaining Employment - - Prova Education
Advanced Bladder Cancer Patients Could Keep Their Bladder Under New Treatment Regime, Clinical Trial Shows
Clinical Trials Roswell Park Comprehensive Cancer Center - Buffalo, NY
JCI - Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer
Towards Immunotherapy for Pediatric Brain Tumors: Trends in Immunology
SITC Cancer Immunotherapy CONNECT - Society for Immunotherapy of Cancer (SITC)
Cancer vaccines: the next immunotherapy frontier
New approaches to immunotherapy for glioblastoma - Mayo Clinic
